Clinical Delivery of Pharmacogenetic Testing Services: A Proposed Partnership Between Genetic Counselors and Pharmacists
- 7 June 2013
- journal article
- Published by Taylor & Francis Ltd in Pharmacogenomics
- Vol. 14 (8), 957-968
- https://doi.org/10.2217/pgs.13.76
Abstract
One of the basic questions in the early uses of pharmacogenetic (PGx) testing revolves around the clinical delivery of testing. Because multiple health professionals may play a role in the delivery of PGx testing, various clinical delivery models have begun to be studied. We propose that a partnership between genetic counselors and pharmacists can assist clinicians in the delivery of comprehensive PGx services. Based on their expert knowledge of pharmacokinetics and pharmacodynamics, pharmacists can facilitate the appropriate application of PGx test results to adjust medication use as warranted and act as a liaison to the healthcare team recommending changes in medication based on test results and patient input. Genetic counselors are well-trained in genetics as well as risk communication and counseling methodology, but have limited knowledge of pharmaceuticals. The complementary knowledge and skill set supports the partnership between genetic counselors and pharmacists to provide effective PGx testing se...Funding Information
- National Institute of Health (5R01-GM081416-05)
This publication has 110 references indexed in Scilit:
- Insurance Coverage Policies for Personalized MedicineJournal of Personalized Medicine, 2012
- Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT ProjectClinical Pharmacology & Therapeutics, 2012
- Professional Perspectives About Pharmacogenetic Testing and Managing Ancillary FindingsGenetic Testing and Molecular Biomarkers, 2012
- Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19European Journal of Clinical Pharmacology, 2011
- Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditionsGenetics in Medicine, 2011
- Genomics and Drug ResponseThe New England Journal of Medicine, 2011
- Survey of US public attitudes toward pharmacogenetic testingThe Pharmacogenomics Journal, 2011
- Clinical assessment incorporating a personal genomeThe Lancet, 2010
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side EffectsJournal of the American College of Cardiology, 2009
- Addressing the Challenges of the Clinical Application of Pharmacogenetic TestingClinical Pharmacology & Therapeutics, 2009